Release Date: 24/10/22 10:19 Summary: Quarterly Cashflow Report Price Sensitive: Yes Download Document 210.41KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%